The reduction in cardiac glucose uptake was independent of changes in markers of cardiac stress/injury (atrial natriuretic peptide [ANP] and b-type natriuretic peptide [BNP]) and pathological cardiac hypertrophy (shift in α- to β- myosin heavy chain) (ESM Fig. 1b). Here, NPPA is linked to cardiac hypertrophy.